Parallel neurodegenerative phenotypes in sporadic Parkinson's disease fibroblasts and midbrain dopamine neurons

被引:7
|
作者
Corenblum, M. J. [1 ]
McRobbie-Johnson, A. [2 ]
Carruth, E. [3 ]
Bernard, K. [2 ]
Luo, M. [4 ]
Mandarino, L. J. [4 ]
Peterson, S. [5 ]
Sans-Fuentes, M. A. [5 ]
Billheimer, D. [5 ]
Maley, T. [2 ]
Eggers, E. D. [6 ,7 ]
Madhavan, L. [1 ,8 ,9 ,10 ]
机构
[1] Univ Arizona, Dept Neurol, Tucson, AZ USA
[2] Univ Arizona, Physiol Sci Grad Program, Tucson, AZ USA
[3] Univ Arizona, Physiol Undergraduate Program, Tucson, AZ USA
[4] Univ Arizona, Dept Med, Tucson, AZ USA
[5] Univ Arizona, BIO5 Inst, Stat Consulting Lab, Tucson, AZ USA
[6] Univ Arizona, Dept Physiol, Tucson, AZ USA
[7] Univ Arizona, Dept Biomed Engn, Tucson, AZ USA
[8] Univ Arizona, Evelyn McKnight Brain Inst, Tucson, AZ USA
[9] Univ Arizona, BIO5 Inst, Tucson, AZ USA
[10] Univ Arizona, Dept Neurol, 1501,N Campbell Ave, Tucson, AZ 85724 USA
关键词
Skin fibroblasts; Human Induced Pluripotent Stem Cells; Midbrain Dopamine Neurons; Aging; Parkinson 's disease; Mitochondrial Dysfunction; ALPHA-SYNUCLEIN; HUMAN ES; CELLS; MITOCHONDRIA;
D O I
10.1016/j.pneurobio.2023.102501
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Understanding the mechanisms causing Parkinson's disease (PD) is vital to the development of much needed early diagnostics and therapeutics for this debilitating condition. Here, we report cellular and molecular alterations in skin fibroblasts of late-onset sporadic PD subjects, that were recapitulated in matched induced pluripotent stem cell (iPSC)-derived midbrain dopamine (DA) neurons, reprogrammed from the same fibroblasts. Specific changes in growth, morphology, reactive oxygen species levels, mitochondrial function, and autophagy, were seen in both the PD fibroblasts and DA neurons, as compared to their respective controls. Additionally, significant alterations in alpha synuclein expression and electrical activity were also noted in the PD DA neurons. Interestingly, although the fibroblast and neuronal phenotypes were similar to each other, they differed in their nature and scale. Furthermore, statistical analysis revealed potential novel associations between various clinical measures of the PD subjects and the different fibroblast and neuronal data. In essence, these findings encapsulate spontaneous, in-tandem, disease-related phenotypes in both sporadic PD fibroblasts and iPSC-based DA neurons, from the same patient, and generates an innovative model to investigate PD mechanisms with a view towards rational disease stratification and precision treatments.
引用
收藏
页数:20
相关论文
共 50 条
  • [31] Dilated Perivascular Space in the Midbrain May Reflect Dopamine Neuronal Degeneration in Parkinson's Disease
    Li, Yanxuan
    Zhu, Zili
    Chen, Jie
    Zhang, Minming
    Yang, Yunjun
    Huang, Peiyu
    FRONTIERS IN AGING NEUROSCIENCE, 2020, 12
  • [32] DISEASE STRATIFICATION IN SPORADIC PARKINSON'S DISEASE
    Carling, Philippa
    Mortiboys, Heather
    Mihaylov, Simeon
    Clemmens, Hannah
    Schwartzenhuber, Aurelie
    Wade-Martins, Richard
    Talbot, Kevin
    Hu, Michele
    Bandmann, Oliver
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2017, 88 : A31 - A32
  • [33] 'Atypical' Parkinson's disease - sporadic
    Zeuner, Kirsten E.
    Berg, Daniela
    PARKINSONISM BEYOND PARKINSON'S DISEASE, 2019, 149 : 195 - 206
  • [34] The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
    Burbulla, Lena F.
    Krueger, Rejko
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2012, (68):
  • [35] Pathophysiology of Sporadic Parkinson's Disease
    Braak, H.
    Del Tredici, K.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2010, 78 : S2 - S4
  • [36] No relevant midbrain atrophy in Parkinson's disease
    Makinen, E.
    Joutsa, J.
    Isotalo, J.
    Kaasinen, V.
    ACTA NEUROLOGICA SCANDINAVICA, 2016, 134 (05): : 378 - 381
  • [37] Dopamine in Parkinson's disease
    Latif, Saad
    Jahangeer, Muhammad
    Razia, Dure Maknoon
    Ashiq, Mehvish
    Ghaffar, Abdul
    Akram, Muhammad
    El Allam, Aicha
    Bouyahya, Abdelhakim
    Garipova, Larisa
    Shariati, Mohammad Ali
    Thiruvengadam, Muthu
    Ansari, Mohammad Azam
    CLINICA CHIMICA ACTA, 2021, 522 : 114 - 126
  • [38] Dopamine across timescales and cell types: Relevance for phenotypes in Parkinson's disease progression
    Seiler, Jillian L.
    Zhuang, Xiaowen
    Nelson, Alexandra B.
    Lerner, Talia N.
    EXPERIMENTAL NEUROLOGY, 2024, 374
  • [39] Modeling early phenotypes of Parkinson's disease by age-induced midbrain-striatum assembloids
    Barmpa, Kyriaki
    Saraiva, Claudia
    Lopez-Pigozzi, Diego
    Gomez-Giro, Gemma
    Gabassi, Elisa
    Spitz, Sarah
    Brandauer, Konstanze
    Gatica, Juan E. Rodriguez
    Antony, Paul
    Robertson, Graham
    Sabahi-Kaviani, Rahman
    Bellapianta, Alessandro
    Papastefanaki, Florentia
    Luttge, Regina
    Kubitscheck, Ulrich
    Salti, Ahmad
    Ertl, Peter
    Bortolozzi, Mario
    Matsas, Rebecca
    Edenhofer, Frank
    Schwamborn, Jens C.
    COMMUNICATIONS BIOLOGY, 2024, 7 (01)
  • [40] Protein aggregation and calcium dysregulation are hallmarks of familial Parkinson’s disease in midbrain dopaminergic neurons
    Gurvir S. Virdi
    Minee L. Choi
    James R. Evans
    Zhi Yao
    Dilan Athauda
    Stephanie Strohbuecker
    Raja S. Nirujogi
    Anna I. Wernick
    Noelia Pelegrina-Hidalgo
    Craig Leighton
    Rebecca S. Saleeb
    Olga Kopach
    Haya Alrashidi
    Daniela Melandri
    Jimena Perez-Lloret
    Plamena R. Angelova
    Sergiy Sylantyev
    Simon Eaton
    Simon Heales
    Dmitri A. Rusakov
    Dario R. Alessi
    Tilo Kunath
    Mathew H. Horrocks
    Andrey Y. Abramov
    Rickie Patani
    Sonia Gandhi
    npj Parkinson's Disease, 8